Stock Events

Stock Events

Noveris Health Sciences 

$1.32
38
+$0.19+16.64% Monday 20:00

Statistics

Day High
1.34
Day Low
1.13
52W High
1.4
52W Low
0.03
Volume
200
Avg. Volume
181
Mkt Cap
1.63M
P/E Ratio
0.87
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19MayExpected
Q2 2024
Q3 2024
Q4 2024
Q2 2025
Q3 2025
Q4 2025
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-4.61MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MYCOF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap746.47M
Compass Pathways focuses on psilocybin therapy for mental health disorders, directly competing in the psychedelic medicine space with Mydecine Innovations.
AtaiBeckley
ATAI
Mkt Cap1.38B
ATAI Life Sciences is a biotech company working on mental health treatments using psychedelics, overlapping with Mydecine's focus areas.
GH Research
GHRS
Mkt Cap903.77M
GH Research focuses on developing 5-MeO-DMT therapies for depression, competing in the psychedelic treatment market.
Revive Therapeutics
RVVTF
Mkt Cap12.2M
Revive Therapeutics is exploring the use of psychedelics for medical treatments, including areas Mydecine Innovations is involved in.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness is engaged in psychedelic production and therapy, directly competing with Mydecine's business model.
TripAdvisor
TRIP
Mkt Cap1.27B
Red Light Holland is involved in the production and sale of recreational truffles, indirectly competing by promoting psychedelic acceptance.

About

Noveris Health Sciences Inc. is a biotechnology company, which engages in the research, drug development, and clinical trials of psilocybin products. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Robert Roscow M.A.
Employees
3
Country
US
ISIN
CA66990B1085

Listings

STU
DE
0NF1.STU
OTC Link
US
MYCOF
CN
CA
NVRS.CN
F
DE
0NF1.F

0 Comments

Share your thoughts

FAQ

What is Noveris Health Sciences stock price today?▼
The current price of MYCOF is $1.32 USD — it has increased by +16.64% in the past 24 hours. Watch Noveris Health Sciences stock price performance more closely on the chart.
What is Noveris Health Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Noveris Health Sciences stocks are traded under the ticker MYCOF.
Is Noveris Health Sciences stock price growing?▼
MYCOF stock has risen by +16.64% compared to the previous week, the month change is a +711.58% rise, over the last year Noveris Health Sciences has showed a +370.71% increase.
What is Noveris Health Sciences market cap?▼
Today Noveris Health Sciences has the market capitalization of 1.63M
When is the next Noveris Health Sciences earnings date?▼
Noveris Health Sciences is going to release the next earnings report on May 19, 2026.
What is Noveris Health Sciences revenue for the last year?▼
Noveris Health Sciences revenue for the last year amounts to 0 USD.
What is Noveris Health Sciences net income for the last year?▼
MYCOF net income for the last year is -4.61M USD.
How many employees does Noveris Health Sciences have?▼
As of April 10, 2026, the company has 3 employees.
In which sector is Noveris Health Sciences located?▼
Noveris Health Sciences operates in the Health Care sector.
When did Noveris Health Sciences complete a stock split?▼
The last stock split for Noveris Health Sciences was on October 21, 2025 with a ratio of 1:50.
Where is Noveris Health Sciences headquartered?▼
Noveris Health Sciences is headquartered in Vancouver, US.